OquiliaOquiliaOquilia — India's Financial Intelligence Platform
Calculators
Compare
Tax
NRI
News
Consult
Oquilia Advisor
HomeCalculatorsConsultNews

Talk to Subodh Bajpai · Advocate

Free 15-min phone consultation. No payment, no signup.

+91 84008 60008Or view paid consultations from ₹5,000 →
View All CalculatorsSIP CalculatorEMI CalculatorIncome TaxFD CalculatorPPF CalculatorAll 150+ Calculators
View All CompareHome Loan RatesPersonal LoansCredit CardsHealth InsuranceTerm InsuranceMutual FundsFD RatesEducation Loan
View All TaxOld vs New RegimeTax Saving under 80CIncome Tax Slabs 2025Capital Gains TaxSave Tax on SalaryITR Filing Guide
View All NRINRI Investment GuideNRI Tax FilingNRI Banking & NRE FDNRI Real EstateDTAA CalculatorNRE FD Calculator
View All NewsLatest NewsSubodh's Law ColumnSARFAESI DefenceBlog / GuidesReports
View All ConsultFree 15-min call · +91 84008 60008DTAA Review · ₹5,000FEMA Compounding · ₹15,000NRI Tax Filing Review · ₹7,500About Subodh Bajpai, Advocate
View All ToolsAm I Underinsured?Policy AuditJargon DecoderMutual Fund Discovery
For Business
View All LearnFinancial GlossaryFAQAbout OquiliaContact
Oquilia Advisor
  1. Home
  2. News
  3. Inside Vegas's $25 Million Olympics Where Doping Is the Point
Startups

Inside Vegas's $25 Million Olympics Where Doping Is the Point

Forty-two athletes compete this Sunday on FDA-approved drugs for a $25 million purse, and India's quietly booming longevity startup scene is taking notes.

Oquilia Newsroom
Financial news desk covering SEBI, RBI, IRDAI, and Budget-related developments.
|3 min read · 704 words
Verified Sources|Last reviewed: 24 May 2026
Inside Vegas's $25 Million Olympics Where Doping Is the Point — Startups on Oquilia

The News

Forty-two athletes gather in Las Vegas this Sunday for the inaugural Enhanced Games, where participants are openly encouraged to take performance-enhancing drugs. Organisers say competitors will use only FDA-approved substances under medical supervision, alongside what they call "technological doping" - equipment such as polyurethane swimsuits banned from Olympic competition since 2009.

The prize pool runs to $25 million, with up to $1 million for each world record broken. Four disciplines feature: swimming, track and field, weightlifting, and strongman events. Many entrants hold national or world records and several are former Olympic medallists. Swimmer Kristian Gkolomeev, who broke a 50-metre freestyle record in a super-suit in 2025, walked away with $1 million for that feat alone.

World Aquatics has already banned Enhanced Games entrants from its sanctioned events. World Athletics president Sebastian Coe called participants "moronic". The hostility has not slowed sign-ups.

Why It Matters

The Enhanced Games are best read not as a sporting curiosity but as the loudest signal yet of what MIT Technology Review writer Jessica Hamzelou calls 2026's "enhancement era". Peptide protocols once confined to private clinics now sit on supplement shelves. Longevity clinics, most of them selling treatments without solid efficacy data, are opening at pace. Embryo screening services that promise to optimise unborn children are in active commercial rollout.

The trajectory mirrors how online sports betting moved from fringe to mainstream. The 2018 US Supreme Court ruling in Murphy v. NCAA cleared the way for state-by-state legalisation, and the American sports betting market reached roughly $150 billion in annual handle by 2024. The enhancement category is travelling a faster curve, and Vegas is its first proper stage.

Indian Angle

India's longevity scene has built quietly through 2024 and 2025 and is about to face the same legitimacy question. Chennai-based Decode Age has scaled NMN and NAD-precursor supplements into Indian pharmacies. Bangalore's Pluto Health and Mumbai's Wellbeing Nutrition sit in adjacent biohacking and longevity-supplement lanes. Bryan Johnson's high-profile India visits have pulled the conversation out of fitness-influencer territory and into mainstream business media.

The Enhanced Games will also force a regulator-level reaction. The National Anti-Doping Agency (NADA) India, set up under the Sports Ministry in 2009, has spent recent seasons on the back foot. Wrestler Vinesh Phogat's 100-gram weight disqualification at Paris 2024 and a string of athlete bans at the 2023 Asian Games damaged its public standing. A Vegas spectacle in which doping is the selling point hardens the binary NADA enforces at home, even as elite Indian athletes watch peers from other countries compete in the open category.

For founders, the practical question is regulatory framing. Indian longevity products today live in the supplement and ayurveda lane, not the pharmaceutical one. Enhanced Games-style normalisation could pull adventurous Indian capital toward the drug end of the spectrum, and force the Central Drugs Standard Control Organisation (CDSCO) to draw a line on senolytics, peptides and gene-modulating compounds well before the West settles its own debate.

FAQ

When does the Enhanced Games event take place?

The inaugural competition opens this Sunday in Las Vegas. Forty-two athletes will compete across swimming, track and field, weightlifting, and strongman events. Future editions have not yet been publicly scheduled.

How much money is on the table?

The total prize pool is $25 million. Athletes earn up to $1 million for each world record broken, plus salaries from the organising company on top of any competition winnings.

Are participants banned from mainstream sport?

World Aquatics has banned Enhanced Games swimmers from its sanctioned competitions. World Athletics has been equally hostile. Most participants are treating Vegas as a one-way exit from federated sport.

What does this mean for Indian longevity startups?

A small but funded cluster - Decode Age, Pluto Health, Wellbeing Nutrition - sits in adjacent supplement and biohacking categories. Mainstream coverage of the games could accelerate Indian consumer adoption of NMN, peptide and senolytic products, while sharpening the regulatory line CDSCO eventually has to draw.

Where can I read the original report?

MIT Technology Review's Jessica Hamzelou wrote the original framing piece on the 2026 enhancement era. The full article is linked below.

This story was reported by MIT Technology Review. Read the full original coverage at MIT Technology Review.

Sources & Citations

  1. The Enhanced Games fit right in with the rest of 2026's longevity vibes — MIT Technology Review

This article was last reviewed on 24 May 2026by Oquilia's editorial team. Every claim is sourced from primary regulatory materials (CBDT, IRDAI, RBI, SEBI, Indian Kanoon). View our methodology.

Found an error? Report an issue.

CalculatorsInsuranceInvestTaxLoansNRIMBAHNIAI
Oquilia

150+ calculators · Zero commissions

Oquilia

Intelligent financial analysis. 150+ calculators & unbiased analysis.

Data: IRDAI · RBI · SEBI · AMFI

Calculators

  • SIP
  • EMI
  • Income Tax
  • FD
  • PPF
  • NPS
  • Gratuity
  • HRA
  • ELSS
  • All 150+

Insurance

  • Compare Plans
  • Companies
  • Claims Data
  • Hospitals
  • Health Premium
  • Term Premium
  • Section 80D

Tax & Loans

  • Old vs New
  • Capital Gains
  • TDS
  • Home Loan EMI
  • Car Loan EMI
  • Rent vs Buy
  • Prepayment

More Tools

  • Invest Hub
  • Tax Planning
  • Loan Tools
  • Loan Harassment Help
  • NRI Hub
  • MBA Finance
  • HNI Wealth
  • Glossary
  • News
  • Blog
  • Reports
  • Tools
  • Oquilia Advisor

Company

  • About
  • Contact
  • FAQ
  • Legal Hub
  • Privacy
  • Terms
  • Disclaimer
  • Cookie Policy
  • Grievance
  • Disclosure

Newsletter

Monthly digest

Policy moves, deadline reminders, and the most-used calculators each month.

Reviewed by Subodh Bajpai, Senior Partner & MBA Finance (XLRI)

Legal & Grievance Partner: Unified Chambers & Associates, Delhi High Court

Designed & developed by QX137, React & Next.js studio

Regulatory & data sources

RBISEBIIRDAIIncome Tax DeptAMFIPFRDAOECD TaxBISWorld Bank

Regulatory data last updated: May 2026. Figures are cross-checked against primary IRDAI, SEBI, RBI, CBDT and AMFI publications before they ship.

© 2026 Oquilia. Not a licensed financial advisor. All third-party logos and trademarks belong to their respective owners.

PrivacyTermsDisclaimerSitemap